Pharmaron Beijing Co., Ltd. (PHBBF)
1.93
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Pharmaron Beijing Total Assets (Quarterly) : 4.294B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.294B |
| March 31, 2026 | 4.134B |
| December 31, 2025 | 3.900B |
| September 30, 2025 | 3.625B |
| June 30, 2025 | 3.538B |
| March 31, 2025 | 3.355B |
| December 31, 2024 | 3.278B |
| September 30, 2024 | 3.359B |
| June 30, 2024 | 3.165B |
| March 31, 2024 | 3.493B |
| December 31, 2023 | 3.733B |
| September 30, 2023 | 3.077B |
| June 30, 2023 | 3.082B |
| March 31, 2023 | 3.063B |
| December 31, 2022 | 2.948B |
| September 30, 2022 | 2.779B |
| June 30, 2022 | 2.833B |
| Date | Value |
|---|---|
| March 31, 2022 | 2.942B |
| December 31, 2021 | 2.885B |
| September 30, 2021 | 2.714B |
| June 30, 2021 | 2.637B |
| March 31, 2021 | 1.947B |
| December 31, 2020 | 1.821B |
| September 30, 2020 | 1.540B |
| June 30, 2020 | 1.411B |
| March 31, 2020 | 1.308B |
| December 31, 2019 | 1.426B |
| September 30, 2019 | 780.87M |
| June 30, 2019 | 778.55M |
| March 31, 2019 | 765.39M |
| December 31, 2018 | 699.43M |
| September 30, 2018 | 650.71M |
| June 30, 2018 | 643.82M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Viva Biotech Holdings | -- |
| ICON plc | 16.40B |
| Proteome Sciences Plc | -- |
| Champions Oncology, Inc. | 26.99M |
| SPO Global, Inc. | 0.00 |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.715B |
| Shareholders Equity (Quarterly) | 2.409B |
| Debt to Equity Ratio | 0.4253 |
| Current Ratio | 1.017 |
| Net Debt Paydown Yield | -1.15% |